Good summary Jacobmoore. Contributing to the weakness of the S P has been a dearth of information being released to the public. Having said that let me explain why I think this is so. In this business which is highly professional and in which a miss-statement (much less a lie) can be career ending I can understand the reluctance of directors to release any information which may be misconstrued. Therefore in spite of the paucity of information released I believe that all that information can be relied upon with near 100% certainty to be factually correct. That being the case as I see it their product kills cancer cells with no side effects. While I don't agree with the mechanics of the latest fund raising, because of my lack of knowledge of why it was done this way, I hesitate to criticize too loudly.
PAB Price at posting:
3.2¢ Sentiment: ST Buy Disclosure: Held
